Patients Understanding their Cancer and Treatment Options
Gary Palmer, MD
Video Categories: Targeted Therapies
Alexander Bastian speaks about the need for a sustainable model of pricing as related to cancer treatments and drug development. He talks about indication-based pricing or tumor-based pricing—says that is compelling, but not necessarily possible in the US.
Dr. Michaelis discusses what approaches she takes for PV patients with unmet clinical needs such as recurrent thrombosis or hemorrhage. Supported through funding from Incyte